Key facts
- What it is
- Growing and condition-specific. Clinical studies and extensive practice experience report benefits, while certainty varies by outcome.
- Typical course
- There is no evidence-based standard course. Agree goals and a review point before booking multiple sessions.
- Cost per session
- Prices vary substantially by country, setting, and practitioner; ask about the full cost before treatment.
- Who it may suit
- People considering it as an optional complement, not a replacement for appropriate medical assessment and care.
- Safety profile
- Published trials report few serious adverse events, but reporting is limited. Check the medical red flags below.
Headaches and migraines are one of the most common reasons people seek out craniosacral therapy. When medication helps but doesn't fully resolve the pattern, or when side effects become a burden, people often look for something gentler. CST's light-touch approach to the head, neck, and spine makes it a natural fit for headache work — though the evidence, as always, is worth understanding honestly.
Headache-specific red flags and when to seek urgent medical care: do not book a CST session, and seek urgent medical assessment (same-day GP, urgent care, A&E, or call 999/112), if you have any of the following — a sudden severe headache reaching maximum intensity within seconds to minutes (thunderclap headache: this is the cardinal sign of subarachnoid haemorrhage, a life-threatening brain bleed that needs same-day CT scan and neurological review); a first or worst headache of your life; any new neurological symptoms accompanying the headache, including weakness, numbness, visual loss, double vision, slurred speech, confusion, or difficulty walking (possible stroke, TIA, or mass lesion); fever, stiff neck, or rash with headache (possible meningitis or encephalitis — needs same-day assessment and possibly lumbar puncture); headache that wakes you from sleep, is worse on waking, or worsens with coughing, sneezing or bending forward (possible raised intracranial pressure — needs urgent imaging); new-onset severe headache after age 50, especially with scalp tenderness, jaw pain on chewing, or visual changes (possible giant cell arteritis / temporal arteritis — needs same-day steroid treatment to prevent permanent sight loss); headache during pregnancy or the postpartum period, especially with high blood pressure, visual disturbance, or swelling (possible pre-eclampsia or cerebral venous sinus thrombosis); a headache that is positional (much worse standing, relieved by lying flat, or the reverse — possible CSF leak or intracranial hypotension/hypertension); a rapidly increasing frequency or severity of headaches, or a clear change in the pattern of your usual headaches; headache after recent head injury or trauma; new headache in someone with a history of cancer, HIV, or immunosuppression (possible opportunistic infection or metastasis); or severe eye pain with nausea, halos around lights, or visual loss (possible acute angle-closure glaucoma — an ophthalmic emergency). Each of these requires medical assessment first — not bodywork. If you are unsure whether your symptoms are safe for manual therapy, contact your GP, neurologist, NHS 111, or local urgent care service before booking.
How craniosacral therapy helps
What a CST session looks like for someone with headaches or migraines. CST for headaches and migraines focuses on the structures where headache pathways converge: the base of the skull (occiput), the upper cervical vertebrae (C1-C3, which share nerve pathways with the head via the trigeminocervical complex), the temporal bones at the sides of the skull, the jaw (temporomandibular joint), the membranes surrounding the brain and spinal cord (the meninges and dura mater), and the sacrum at the base of the spine. The practitioner uses very light touch — about the weight of a coin — placed at these key points. There is no manipulation, no cracking, no high-velocity thrust, and no deep pressure. The work aims to release restrictions in the cranial membranes and connective tissues, to reduce tension in the suboccipital muscles at the base of the skull, to influence the autonomic nervous system (shifting toward parasympathetic dominance), and to address the fascial continuity that links the neck, jaw, and cranium.
The session typically begins with a full case history: when the headaches started, what type they are (migraine, tension-type, cervicogenic, cluster, medication-overuse), frequency and severity, known triggers, what you have already tried (medication and other therapies), any imaging or neurology review, your sleep, stress and work patterns, and any red-flag symptoms (see the safety section above). The practitioner may also assess your jaw (clicking, clenching, bruxism), neck range of motion, and posture. You then lie fully clothed on a treatment table, usually face-up. The practitioner places their hands gently on your skull, under your head, at the base of your neck, and sometimes at your sacrum, feet, or along your spine. The touch is so light you may barely feel it at times. Sessions are typically deeply relaxing, and many clients report a sense of softening in areas that have felt tight, a shift in breathing pattern, or a lessening of head pressure during or after the session.
Two features distinguish CST from higher-force approaches for headaches. First, the very low contact force means there is essentially no mechanical risk to the neck or head from a properly trained practitioner — relevant for people who find deeper neck work too painful or overstimulating, who have been told to avoid cervical manipulation, or who are sensitive to touch during a migraine attack. Second, CST's whole-body approach reflects the premise that headache patterns are rarely isolated to the head — they involve the neck, jaw, nervous system regulation, stress response, breathing, and fascial tension throughout the body. A typical initial course is 3 to 6 sessions over 4 to 8 weeks, with a clear reassessment at the end of that window. CST should be used alongside, not instead of, an optimised medical headache plan.
What the evidence says
A 2023 systematic review of four randomized controlled trials found a statistically significant reduction in headache pain intensity with CST — about 1.1 points on a 10-point scale. The researchers rated this as 'clinically unimportant' and the evidence certainty as 'very low.' A broader 2024 meta-analysis across 15 RCTs concluded CST produced no clear benefits for musculoskeletal conditions including headache. However, smaller studies and patient surveys consistently report that some headache sufferers experience meaningful relief. The honest picture: CST helps some people with headaches, doesn't help others, and we don't yet have strong evidence to predict who will respond. The safety profile is excellent, making it a reasonable thing to try if other approaches haven't worked.
Studies and reviews worth knowing for headaches, migrages and CST:
• Cochrane-style systematic review of CST for headache (2023) — a review of four randomised controlled trials of CST for headache conditions found a statistically significant reduction in pain intensity of approximately 1.1 points on a 10-point visual analogue scale. However, the reviewers rated this effect as below the threshold most consider clinically important (the minimum clinically important difference for headache pain is typically cited as 1.5-2.0 points), and graded the evidence certainty as 'very low' due to risk of bias, small sample sizes, and heterogeneity. This is the most direct CST-for-headache evidence to date, and it is modest. • Haller et al. 2019 (PMID 31892357) — a systematic review and meta-analysis of CST for chronic pain syndromes (including headache subgroups) that found significant short-term effects on pain (SMD approximately -0.32) and disability compared with sham or no treatment. Evidence quality rated as moderate for short-term outcomes. • Haller et al. 2022 — an updated and expanded meta-analysis of CST across pain and functional outcomes, including headache and migraine subgroups, confirming small-to-moderate short-term effects on pain intensity and disability. The authors note that long-term effects remain uncertain and that larger, higher-quality trials are needed. • Jäkel & von Hauenschild 2019 — a systematic review of the therapeutic effects of CST that concluded the overall evidence base is limited but with the strongest signals in chronic pain conditions, including headache. • NICE CG150 (2012, updated 2021) — the UK National Institute for Health and Care Excellence guideline on headaches in over-12s: diagnosis and management. Covers the diagnostic pathway for migraine, tension-type headache, cluster headache and medication-overuse headache; recommends acute treatment (triptans, NSAIDs, paracetamol, anti-emetics), prophylactic treatment (propranolol, topiramate, amitriptyline, and CGRP monoclonal antibodies in specialist care), and lifestyle trigger management. Does NOT specifically recommend manual therapy, including CST, for headache management. • ICHD-3 (International Classification of Headache Disorders, 3rd edition, 2018) — the diagnostic reference published by the International Headache Society, providing the formal criteria for all primary and secondary headache disorders. This is the classification system clinicians use to diagnose migraine, tension-type headache, cervicogenic headache, cluster headache, and medication-overuse headache. • American Headache Society 2021 Consensus Statement and American Academy of Neurology/AAN guidelines on migraine prevention and acute treatment — provide the evidence-based pharmacological framework (acute: triptans, gepants, ditans; preventive: beta-blockers, topiramate, valproate, amitriptyline, onabotulinumtoxinA for chronic migraine, CGRP monoclonal antibodies) within which complementary approaches like CST should be positioned.
Honest limits: the evidence for CST in headache and migraine is modest. The 2023 review pooled only four RCTs with small total sample sizes, the effect was below the clinically important threshold, and the certainty was rated very low. No published RCT has demonstrated that CST reduces migraine frequency, duration, or medication use in a well-controlled design with adequate sample size and follow-up. Blinding in manual therapy RCTs is inherently difficult. The case for CST in headache is that some people report meaningful subjective improvement, the safety profile is excellent, and the short-term pain-reduction signal in the existing trials is consistent enough to warrant trying — but it is not equivalent to the evidence for triptans in acute migraine, CGRP monoclonal antibodies in chronic migraine prevention, or CBT-based approaches in migraine management.
What to expect
People seeking CST for headaches typically start with 3-6 weekly sessions. The practitioner will ask about your headache history, triggers, and what you've already tried. Sessions last 45-75 minutes. You stay fully clothed, lying face-up. Some people notice changes after 1-2 sessions; others need the full course before their headache pattern shifts. It's worth keeping a headache diary to track changes objectively.
Practical next steps if you are considering CST for headaches or migraines:
1. Confirm the diagnosis and rule out red flags with your medical team first. Book a GP or neurologist assessment to confirm what type of headache you have (migraine, tension-type, cervicogenic, cluster, medication-overuse — each has a different best-evidence treatment), to screen for the red flags listed in the introduction, and to discuss whether imaging or referral is needed. If your headache pattern has changed, is new, or comes with any neurological symptoms, this step is non-negotiable. Mention specifically: when the headaches started, how often they occur, how long they last, what they feel like, any associated symptoms (nausea, aura, visual changes, neck pain, jaw pain), what triggers them, and what you have tried so far. 2. Optimise the medical headache plan before or alongside CST. This is the single most important step. If you have migraine, ask your GP or neurologist whether your acute treatment (triptans, NSAIDs, anti-emetics) is optimised — many people with migraine are undertreated. Ask whether you might benefit from preventive medication (propranolol, topiramate, amitriptyline, or CGRP monoclonal antibodies if eligible). If you take acute pain relief more than 10-15 days per month, discuss medication-overuse headache with your doctor. Consider keeping a headache diary (frequency, intensity, triggers, medication use) — this is genuinely useful for the medical plan as well as for tracking whether CST helps. Identify and address modifiable triggers: sleep, hydration, caffeine, alcohol, stress, screen time, posture, meal regularity. 3. Choose a CST practitioner who works within the medical plan. Look for: formal training in CST (a diploma from a recognised CST school), specific experience with headache and migraine clients, willingness to take a full headache history (including type, frequency, triggers, current medication, neurology review status), open conversation about red flags, explicit willingness to refer back to your GP or neurologist if something is unclear or changes, and a clear consent process. A practitioner who pressures you to reduce medication, who promises to 'cure' your migraines, or who positions CST as a replacement for medical treatment is not the right choice. 4. Keep CST as a complement, not a replacement. Plan an initial course of 3 to 6 sessions over 4 to 8 weeks with a clear reassessment conversation at the end. The point is to see whether you — with your specific headache pattern — report subjective improvement (reduced frequency, intensity, duration, or medication use; better sleep; reduced neck and jaw tension) alongside your medical plan. Track with your headache diary so the reassessment is based on data, not impression. 5. Escalate or stop if anything changes. Specific signs that require stopping CST and returning to your medical team include: any new red-flag symptom (see list above — thunderclap headache, new neurological symptoms, fever with neck stiffness, visual changes, etc.); a clear change in your headache pattern; a marked increase in frequency or severity; headaches that are progressively less responsive to your usual acute medication; or no improvement after 4 to 8 weeks of CST alongside an optimised medical plan. If CST makes your headaches worse, tell the practitioner, stop, and contact your GP or neurologist. Most well-trained CST practitioners welcome this conversation — a good practitioner would rather you return to your medical team than push for more sessions when something has changed.
Frequently asked questions
How does craniosacral therapy work for headaches?
+
How does craniosacral therapy work for headaches?
+CST practitioners work with the membranes, bones, and fluid dynamics of the craniosacral system — particularly around the base of the skull, temples, and upper neck. The theory is that restrictions in these tissues can contribute to headache patterns, and gentle, sustained touch helps release them. The light pressure (about the weight of a coin) is directed at areas where tension accumulates.
Is there scientific evidence CST helps migraines?
+
Is there scientific evidence CST helps migraines?
+The evidence is mixed. A 2023 meta-analysis of 4 RCTs found a small but statistically significant reduction in pain intensity. However, the effect was below the threshold most researchers consider clinically meaningful, and the evidence quality was rated 'very low.' Other reviews have found no clear benefit. Some patients report significant relief; the research hasn't yet explained why some respond and others don't.
How many CST sessions are needed for headaches?
+
How many CST sessions are needed for headaches?
+Most people try 3-6 weekly sessions initially. Some notice improvement after 1-2 sessions; others need the full course. Your practitioner should discuss expected pacing with you upfront, and you can reassess together after a few sessions to decide whether to continue.
Is craniosacral therapy safe for headaches?
+
Is craniosacral therapy safe for headaches?
+CST is generally well tolerated because it uses very light, non-forceful touch. Published studies report few serious adverse events, although safety reporting is limited. With a recent head injury, bleeding disorder, or active neurological condition, seek medical guidance before bodywork.
When should I see a doctor first?
+
When should I see a doctor first?
+When to seek medical care first: Craniosacral therapy is a gentle, complementary approach, but it should not replace urgent medical assessment. See a physician promptly if you have any of the following: sudden severe pain unlike anything you've had before; new neurological symptoms (numbness, weakness, vision changes, slurred speech, severe dizziness or balance loss); fever, chills, or other signs of infection; unexplained weight loss; blood in stool, urine, or vomit; new or changing lumps or masses; severe headache with fever, stiff neck, or rash; recent trauma to the head, neck, or spine; pregnancy complications; severe shortness of breath or chest pain; thoughts of self-harm. Trained CST practitioners screen for these and will refer you when needed. Always tell your practitioner about any current or recent medical conditions, pregnancy, medications, blood thinners, recent surgery, cancer history, or implanted devices.
Can craniosacral therapy cure my migraines?
+
Can craniosacral therapy cure my migraines?
+No. CST cannot cure migraine — migraine is a chronic neurological condition with a genetic basis, and no manual therapy can eliminate it. The honest picture is that CST helps some people reduce the frequency, intensity, or duration of their headaches, but it does not work for everyone, and the evidence is modest (a 2023 systematic review of four RCTs found a statistically significant but clinically small reduction in pain intensity, rated as very low certainty). CST should be used alongside an optimised medical plan (acute treatment with triptans, preventive medication where appropriate, trigger management), not as a replacement. If a practitioner promises to cure your migraines, that is a red flag — look for someone who works within the medical framework and is honest about the evidence.
How does CST compare to medication for migraine prevention?
+
How does CST compare to medication for migraine prevention?
+CST does not have evidence comparable to migraine preventive medications. NICE CG150 and American Headache Society guidelines recommend evidence-based preventive treatments such as propranolol, topiramate, amitriptyline, and CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) for eligible patients. These have been tested in large, well-designed RCTs. CST's evidence base consists of a few small trials showing modest short-term pain reduction — it has not been tested against preventive medication in a head-to-head trial, and no published RCT has demonstrated that CST reduces migraine frequency or duration in a well-controlled design. CST may be a reasonable complementary approach for people who cannot tolerate preventive medication, who have not responded adequately, or who prefer to try non-pharmacological options first — but it should not replace medically-recommended prevention without discussion with your neurologist or GP.
Is CST safe for headaches during pregnancy?
+
Is CST safe for headaches during pregnancy?
+CST uses very light touch and is generally considered safe during pregnancy by practitioners, but there is no published RCT evidence specifically for CST in pregnancy-related headache. Headache during pregnancy and the postpartum period requires medical assessment first — it can be a sign of pre-eclampsia (especially with high blood pressure), cerebral venous sinus thrombosis, or other serious conditions. Many conventional migraine medications are contraindicated in pregnancy, which is one reason some women seek non-pharmacological options. If your GP, midwife, or obstetrician has confirmed the headache is benign and cleared you for complementary therapy, CST may be reasonable to try. Always inform both your maternity care team and your CST practitioner about all treatments you are receiving.
Should I try CST or Botox for chronic migraine?
+
Should I try CST or Botox for chronic migraine?
+These are not interchangeable options. OnabotulinumtoxinA (Botox) for chronic migraine (15 or more headache days per month) is NICE-approved and has strong evidence from two large PREEMPT trials showing significant reduction in headache days. It is delivered by a trained neurologist or headache specialist as a series of injections every 12 weeks. CST is a complementary light-touch manual therapy with modest evidence from small trials. If you have chronic migraine and meet the criteria, discuss Botox or CGRP monoclonal antibodies with your neurologist — these are the evidence-based medical options. Some people use CST alongside these treatments for additional symptom support, but CST should not be chosen instead of NICE-approved medical treatment for chronic migraine without an informed discussion with your headache specialist.
What should I do if CST does not help my headaches?
+
What should I do if CST does not help my headaches?
+If you have completed an initial course of 3 to 6 CST sessions over 4 to 8 weeks and your headaches have not improved — or have worsened — stop and return to your GP or neurologist. Bring your headache diary to that appointment. The next steps may include: reviewing and adjusting your acute or preventive medication; discussing CGRP monoclonal antibodies if you have chronic migraine and have not tried them; referral to a headache specialist or neurology service; reviewing whether your diagnosis is correct (for example, what seems like migraine may include a cervicogenic or medication-overuse component); addressing contributing factors such as sleep apnoea, jaw clenching, cervical dysfunction, or stress. It is also perfectly acceptable to decide CST is not the right approach for you and to try other non-pharmacological options with better evidence for headache, such as CBT for migraine, biofeedback, or acupuncture — discuss these with your medical team.